The MedTech industry in Asia Pacific has experienced a decade of rapid change. Healthcare systems have faced new pressures, patient expectations have evolved, and entrepreneurs have stepped up to meet those challenges. The result is a vibrant ecosystem where startups are shaping the future of care, fueled by local and global investment, technology, and the region’s diverse health needs.
This report is the result of a collaboration between MedTech Innovator and L.E.K. Consulting. Drawing on more than 2,600 startup applications to the MedTech Innovator Asia Pacific Accelerator Program between 2019 and 2025, it provides a detailed view of how the industry is evolving. The data reflects the creativity and resilience of innovators across medical devices, digital health, and in vitro diagnostics, while also highlighting broader shifts in patient needs, models of care, funding patterns, and investor sentiment.
The past decade has brought both disruption and progress, from the pandemic and the rise of telehealth to workforce challenges, new artificial intelligence tools, and a more cautious funding environment. Startups are often the first to respond, adapting quickly to new pressures and pointing the way toward transformative technologies. In Asia Pacific, these innovators are demonstrating not only agility but also increasing sophistication, digital integration, and readiness to lead in AI-enabled healthcare. By understanding these patterns, we hope this report helps investors, policymakers, and healthcare leaders make better decisions that support entrepreneurs and deliver lasting benefits for patients.
For further insights into our analysis, download the full report.
Contact us for more information.
10172025091009